6-(3,4-Dihydro-2H-1,5-benzodioxepin-7-yl)-pyridazin-3(2H)-one
![]() |
- $178 - $1337.24
- Product name: 6-(3,4-Dihydro-2H-1,5-benzodioxepin-7-yl)-pyridazin-3(2H)-one
- CAS: 1156362-84-3
- MF: C13H12N2O3
- MW: 244.25
- EINECS:
- MDL Number:MFCD12078674
- Synonyms:6-(3,4-Dihydro-2H-1,5-benzodioxepin-7-yl)-pyridazin-3(2H)-one;6-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-2,3-dihydropyridazin-3-one;6-(3,4-Dihydro-2H-benzo[b][1,4]dioxepin-7-yl)-2H-pyridazin-3-one;3(2H)-Pyridazinone, 6-(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)-;6-(3,4-Dihydro-2H-benzo[b][1,4]dioxepin-7-yl)pyridazin-3(2H)-one;6-(3,4-Dihydro-2H-benzo[b][1,4]dioxepin-7-yl)pyridazin-3-ol
8 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Matrix Scientific
Package
- 100mg
- 250mg
- 500mg
- 1g
- 2.5G
- 5g
- ManufacturerAK Scientific
- Product number8812DE
- Product description6-(3,4-Dihydro-2H-1,5-benzodioxepin-7-yl)-2,3-dihydropyridazin-3-one
- Packaging100mg
- Price$178
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number8812DE
- Product description6-(3,4-Dihydro-2H-1,5-benzodioxepin-7-yl)-2,3-dihydropyridazin-3-one
- Packaging250mg
- Price$210
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number8812DE
- Product description6-(3,4-Dihydro-2H-1,5-benzodioxepin-7-yl)-2,3-dihydropyridazin-3-one
- Packaging1g
- Price$407
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number8812DE
- Product description6-(3,4-Dihydro-2H-1,5-benzodioxepin-7-yl)-2,3-dihydropyridazin-3-one
- Packaging5g
- Price$991
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0113965
- Product description6-(3,4-DIHYDRO-2H-1,5-BENZODIOXEPIN-7-YL)-2,3-DIHYDROPYRIDAZIN-3-ONE 95.00%
- Packaging1G
- Price$779.78
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0113965
- Product description6-(3,4-DIHYDRO-2H-1,5-BENZODIOXEPIN-7-YL)-2,3-DIHYDROPYRIDAZIN-3-ONE 95.00%
- Packaging2.5G
- Price$1091.99
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0113965
- Product description6-(3,4-DIHYDRO-2H-1,5-BENZODIOXEPIN-7-YL)-2,3-DIHYDROPYRIDAZIN-3-ONE 95.00%
- Packaging5G
- Price$1337.24
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number064935
- Product description6-(3,4-Dihydro-2H-1,5-benzodioxepin-7-yl)-pyridazin-3(2H)-one
- Packaging500mg
- Price$315
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 8812DE | 6-(3,4-Dihydro-2H-1,5-benzodioxepin-7-yl)-2,3-dihydropyridazin-3-one | 100mg | $178 | 2021-12-16 | Buy |
AK Scientific | 8812DE | 6-(3,4-Dihydro-2H-1,5-benzodioxepin-7-yl)-2,3-dihydropyridazin-3-one | 250mg | $210 | 2021-12-16 | Buy |
AK Scientific | 8812DE | 6-(3,4-Dihydro-2H-1,5-benzodioxepin-7-yl)-2,3-dihydropyridazin-3-one | 1g | $407 | 2021-12-16 | Buy |
AK Scientific | 8812DE | 6-(3,4-Dihydro-2H-1,5-benzodioxepin-7-yl)-2,3-dihydropyridazin-3-one | 5g | $991 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0113965 | 6-(3,4-DIHYDRO-2H-1,5-BENZODIOXEPIN-7-YL)-2,3-DIHYDROPYRIDAZIN-3-ONE 95.00% | 1G | $779.78 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0113965 | 6-(3,4-DIHYDRO-2H-1,5-BENZODIOXEPIN-7-YL)-2,3-DIHYDROPYRIDAZIN-3-ONE 95.00% | 2.5G | $1091.99 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0113965 | 6-(3,4-DIHYDRO-2H-1,5-BENZODIOXEPIN-7-YL)-2,3-DIHYDROPYRIDAZIN-3-ONE 95.00% | 5G | $1337.24 | 2021-12-16 | Buy |
Matrix Scientific | 064935 | 6-(3,4-Dihydro-2H-1,5-benzodioxepin-7-yl)-pyridazin-3(2H)-one | 500mg | $315 | 2021-12-16 | Buy |
Properties
Density :1.38±0.1 g/cm3(Predicted)
pka :10.99±0.40(Predicted)
pka :10.99±0.40(Predicted)
Safety Information
Symbol(GHS): |
![]() |
|||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||
Precautionary statements: |
|